BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 27957723)

  • 1. Low kidney uptake of GLP-1R-targeting, beta cell-specific PET tracer,
    Mikkola K; Yim CB; Lehtiniemi P; Kauhanen S; Tarkia M; Tolvanen T; Nuutila P; Solin O
    EJNMMI Res; 2016 Dec; 6(1):91. PubMed ID: 27957723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 64Cu- and 68Ga-labelled [Nle(14),Lys(40)(Ahx-NODAGA)NH2]-exendin-4 for pancreatic beta cell imaging in rats.
    Mikkola K; Yim CB; Fagerholm V; Ishizu T; Elomaa VV; Rajander J; Jurttila J; Saanijoki T; Tolvanen T; Tirri M; Gourni E; Béhé M; Gotthardt M; Reubi JC; Mäcke H; Roivainen A; Solin O; Nuutila P
    Mol Imaging Biol; 2014 Apr; 16(2):255-63. PubMed ID: 24101374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-invasive glucagon-like peptide-1 receptor imaging in pancreas with (18)F-Al labeled Cys(39)-exendin-4.
    Mi B; Xu Y; Pan D; Wang L; Yang R; Yu C; Wan W; Wu Y; Yang M
    Biochem Biophys Res Commun; 2016 Feb; 471(1):47-51. PubMed ID: 26850848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of
    Kimura H; Ogawa Y; Fujimoto H; Mukai E; Kawashima H; Arimitsu K; Toyoda K; Fujita N; Yagi Y; Hamamatsu K; Murakami T; Murakami A; Ono M; Nakamoto Y; Togashi K; Inagaki N; Saji H
    Bioorg Med Chem; 2018 Jan; 26(2):463-469. PubMed ID: 29273416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Cu-64 and Ga-68 Radiolabeled Glucagon-Like Peptide-1 Receptor Agonists as PET Tracers for Pancreatic β cell Imaging.
    Bandara N; Zheleznyak A; Cherukuri K; Griffith DA; Limberakis C; Tess DA; Jianqing C; Waterhouse R; Lapi SE
    Mol Imaging Biol; 2016 Feb; 18(1):90-8. PubMed ID: 25987465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET of glucagonlike peptide receptor upregulation after myocardial ischemia or reperfusion injury.
    Gao H; Kiesewetter DO; Zhang X; Huang X; Guo N; Lang L; Hida N; Wang H; Wang H; Cao F; Niu G; Chen X
    J Nucl Med; 2012 Dec; 53(12):1960-8. PubMed ID: 23139087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approaches to Improve the Pharmacokinetics of Radiolabeled Glucagon-Like Peptide-1 Receptor Ligands Using Antagonistic Tracers.
    Rylova SN; Waser B; Del Pozzo L; Tönnesmann R; Mansi R; Meyer PT; Reubi JC; Maecke HR
    J Nucl Med; 2016 Aug; 57(8):1282-8. PubMed ID: 27127218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [
    Zhang P; Zhao Z; Zhang L; Wu W; Xu Y; Pan D; Wang F; Yang M
    Nucl Med Biol; 2019; 74-75():19-24. PubMed ID: 31450071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulinoma imaging with glucagon-like peptide-1 receptor targeting probe (18)F-FBEM-Cys (39)-exendin-4.
    Xu Y; Pan D; Xu Q; Zhu C; Wang L; Chen F; Yang R; Luo S; Yang M
    J Cancer Res Clin Oncol; 2014 Sep; 140(9):1479-88. PubMed ID: 24838847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and evaluation of 18F-TTCO-Cys40-Exendin-4: a PET probe for imaging transplanted islets.
    Wu Z; Liu S; Hassink M; Nair I; Park R; Li L; Todorov I; Fox JM; Li Z; Shively JE; Conti PS; Kandeel F
    J Nucl Med; 2013 Feb; 54(2):244-51. PubMed ID: 23297075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced Specific Activity by Multichelation of Exendin-3 Leads To Improved Image Quality and In Vivo Beta Cell Imaging.
    Joosten L; Brom M; Peeters H; Heskamp S; Béhé M; Boerman O; Gotthardt M
    Mol Pharm; 2018 Feb; 15(2):486-494. PubMed ID: 29226686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-radiolabeled analogs of exendin-4 for PET imaging of GLP-1 in insulinoma.
    Kiesewetter DO; Gao H; Ma Y; Niu G; Quan Q; Guo N; Chen X
    Eur J Nucl Med Mol Imaging; 2012 Mar; 39(3):463-73. PubMed ID: 22170321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiosynthesis and evaluation of an
    Dialer LO; Jodal A; Schibli R; Ametamey SM; Béhé M
    EJNMMI Radiopharm Chem; 2018; 3(1):1. PubMed ID: 29503858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of A Novel GLP-1R Ligand for PET Imaging of Prostate Cancer.
    Yue Y; Xu Y; Huang L; Pan D; Bai Z; Wang L; Yang R; Yan J; Song H; Li X; Yang M
    Anticancer Agents Med Chem; 2019; 19(4):509-514. PubMed ID: 30068284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo imaging of the glucagonlike peptide 1 receptor in the pancreas with 68Ga-labeled DO3A-exendin-4.
    Selvaraju RK; Velikyan I; Johansson L; Wu Z; Todorov I; Shively J; Kandeel F; Korsgren O; Eriksson O
    J Nucl Med; 2013 Aug; 54(8):1458-63. PubMed ID: 23761918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo imaging of transplanted islets with 64Cu-DO3A-VS-Cys40-Exendin-4 by targeting GLP-1 receptor.
    Wu Z; Todorov I; Li L; Bading JR; Li Z; Nair I; Ishiyama K; Colcher D; Conti PE; Fraser SE; Shively JE; Kandeel F
    Bioconjug Chem; 2011 Aug; 22(8):1587-94. PubMed ID: 21692471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exendin-4-based radiopharmaceuticals for glucagonlike peptide-1 receptor PET/CT and SPECT/CT.
    Wild D; Wicki A; Mansi R; Béhé M; Keil B; Bernhardt P; Christofori G; Ell PJ; Mäcke HR
    J Nucl Med; 2010 Jul; 51(7):1059-67. PubMed ID: 20595511
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.